Cargando...
An Updated Analysis of Four Randomized ECOG Trials of High-Dose Interferon in the Adjuvant Treatment of Melanoma
BACKGROUND: The pivotal trials of adjuvant high-dose interferon alpha (HDI) in E1684, E1690, E1694 and E2696 enrolled almost 2000 patients, and established HDI as the standard of care for adjuvant therapy of resected high-risk melanoma. Here, we present an updated analysis of these four trials. METH...
Gardado en:
| Publicado en: | Cancer |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7428054/ https://ncbi.nlm.nih.gov/pubmed/31067358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32162 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|